Showing results (11-20 of 205) with videos related to

Sort By:
Pageof 21
Oncogene|October 25, 2003
Mechanisms of resistance to STI571 in Philadelphia chromosome-associated leukemiasNeil P Shah, Charles L Sawyers
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2011
Is it downhill from here? Eliminating leukemic stem cells and curing chronic myeloid leukemiaCatherine C Smith, Neil P Shah
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Mechanisms of resistance to targeted therapies in acute myeloid leukemia and chronic myeloid leukemiaCatherine C Smith, Neil P Shah
Hematology. American Society of Hematology. Education Program|December 14, 2011
Tyrosine kinase inhibitor therapy for chronic myeloid leukemia: approach to patients with treatment-naive or refractory chronic-phase diseaseCatherine C Smith, Neil P Shah
Blood|April 16, 2025
How I individualize treatment for chronic-phase CMLAriel Monet Leyte-Vidal, Neil P Shah
Blood|May 17, 2014
A(nother) RAF mutation in LCHKevin Shannon, Michelle Hermiston
Current Opinion in Genetics & Development|February 8, 2003
Mouse cancer models as a platform for performing preclinical therapeutic trialsBrian Weiss, Kevin Shannon
Cold Spring Harbor Perspectives in Medicine|August 6, 2017
Mechanistic and Preclinical Insights from Mouse Models of Hematologic Cancer Characterized by Hyperactive RasAnica Wandler, Kevin Shannon
The Journal of Experimental Medicine|March 7, 2023
Sidestepping SHP2 inhibitionBogdan Popescu, Kevin Shannon
Clinical Advances in Hematology & Oncology : H&O|March 14, 2015
Integrating current treatment options for TKI-resistant chronic myeloid leukemiaJerald P Radich, Neil P Shah, Michael J Mauro
Pageof 21